Please use this identifier to cite or link to this item:
|Title:||Phosphopeptide microarrays for comparative proteomic pro fi ling of cellular lysates||Authors:||Gao, L.
Comparative proteomic pro filing
|Issue Date:||2013||Citation:||Gao, L.,Sun, H.,Uttamchandani, M.,Yao, S.Q. (2013). Phosphopeptide microarrays for comparative proteomic pro fi ling of cellular lysates. Methods in Molecular Biology 1002 : 233-251. ScholarBank@NUS Repository. https://doi.org/10.1007/978-1-62703-360-2_19||Abstract:||Protein phosphorylation is one of the most important and well-studied posttranslational modi fi cations. Aberrant phosphorylation causes a wide spectrum of diseases, including cancers. As a result, many of the proteins involved in these pathways are seen as vital drug targets and biomarkers in treatment and diagnosis. The availability of broad-based platforms that identify changes across cellular states is critical in understanding unique disease characteristics and changes at the proteomic level. To highlight how microarrays can be applied in this regard, we describe here a comparative proteomic pro fi ling method using two-color sample labeling and application on phosphopeptide microarrays, followed by a pull-down strategy and MS-based protein identi fi cation. This strategy has been applied to uncover candidate biomarkers in breast cancer and colon cancer cell lines. Apart from the synthesis of the phosphopeptide libraries and growth/ isolation of cellular lysates, the protocol takes approximately 15 days to complete, once key steps have been optimized, and can be readily extended to other similarly complex biological specimens/samples.||Source Title:||Methods in Molecular Biology||URI:||http://scholarbank.nus.edu.sg/handle/10635/95570||ISBN:||9781627033596||ISSN:||10643745||DOI:||10.1007/978-1-62703-360-2_19|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Mar 24, 2020
checked on Mar 29, 2020
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.